Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,859.00    42.00 (2.31%)
Bid:
1,856.00
Ask:
1,858.00
Spread: 2.00 (0.108%)
Market Cap: £2.08b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Director/PDMR Shareholding

14 Aug 2019 16:00

RNS Number : 0799J
Derwent London PLC
14 August 2019
Β 

For immediate release

Β 

Β 

Derwent London plcΒ ("Derwent London"/"the Company")

Β 

Notification of interests of Directors and Persons DischargingManagerial Responsibility ("PDMR")

Β 

Β 

The Company announces the following changes to the interests of Directors in the Company's ordinary shares of 5p each ('Shares').

Β 

Grant of Award

Β 

Paul Williams was granted a share-based Award under the Derwent London Performance Share Plan 2014 (PSP) in March 2019 which reflected his 2019 pro rata salary as a Property Director. As disclosed in our 2018 Annual Report (page 121), the Remuneration Committee had agreed a further Award would be made in August to reflect Paul's new pro rata salary as Chief Executive. Accordingly, on 14 August 2019, the Company granted the following share-based Award under the PSP.

Β 

Name

Role

PSP Award

(Number)

Paul M Williams

Chief Executive

6,713

Β 

The Award, granted under the PSP (structured as nil cost options), will vest on 14 August 2022 but only to the extent that certain performance conditions based on total shareholder return and total property return are satisfied over a three-year performance period which ends on 31Β December 2021. No consideration is payable on the grant or vesting of an Award.

Β 

Following vesting and subject to the Company's share dealing procedures, PSP Awards can be exercised at any time up until the tenth anniversary of grant.

Β 

Paul Williams is required to retain the net of tax liability number of vested Shares (if any) delivered under his Award for at least two years from the point of vesting (the 'Holding Period') and is entitled to additional vesting shares for dividend equivalents in respect of dividends paid on vested shares between the grant date and the earlier of the date of exercise or the expiry of the Holding Period.

Β 

This announcement is made in accordance with Article 19 of the Market Abuse Regulation and Rule 3.1 of the Disclosure and Transparency Rules.

Β 

The Company was notified of the grant of all Awards on 14 August 2019.

Β 

Β 

Enquiries:

D A Lawler

Company Secretary

Β 

14 August 2019

Β 

020 7659 3000

www.derwentlondon.com

Β 

Β 

The information set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Β 

Β 

Β 

Β 

Β 

1.

Details the person discharging managerial responsibilities / person closely associated

a)

Name

Paul M Williams

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / Amendment

Initial notification

Β 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Β Derwent London plc

b)

LEI

Β 213800BXKQ9KZNUR1M61

4.

Details of the transaction (s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Β 

5p Ordinary shares in Derwent London plc

Β 

GB0002652740

b)

Nature of the transaction

Grant of a nil cost option award under the Derwent London Performance Share Plan 2014.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

6,713

Β 

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β 

Not applicable - single transaction

e)

Date of the transaction

14 August 2019

f)

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHLLFVVTTISLIA
Date   Source Headline
8th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20262:00 pmRNSHolding(s) in Company
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:37 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20265:15 pmRNSDirector/PDMR Shareholding
19th May 202610:00 amRNSDirector Declaration
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202611:45 amRNSResult of AGM
12th May 20267:00 amRNSTrading Statement
1st May 202610:30 amRNSHolding(s) in Company
30th Apr 20264:45 pmRNSTotal Voting Rights
22nd Apr 20265:00 pmRNSHolding(s) in Company
22nd Apr 202610:15 amRNSHolding(s) in Company
20th Apr 202610:30 amRNSHolding(s) in Company
14th Apr 202611:14 amRNSAnnual Financial Report
10th Apr 20264:45 pmRNSAdmission to Trading
7th Apr 20265:12 pmRNSEmployee Benefit Trust (“EBT”)
7th Apr 20264:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSAppointment of Barclays as joint corporate broker
1st Apr 20267:00 amRNSDisposal of Horseferry House SW1
31st Mar 20264:45 pmRNSTotal Voting Rights
27th Mar 202612:45 pmRNSDirector/PDMR Shareholding
24th Mar 202610:30 amRNSDirector/PDMR Shareholding
20th Mar 20264:15 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSNetwork building fully pre-let
16th Mar 20267:00 amRNSNetwork building fully pre-let
27th Feb 20264:45 pmRNSTotal Voting Rights
26th Feb 20267:32 amRNSDerwent London plc Disposal of 90 Whitfield Street
26th Feb 20267:00 amRNSResults for the Year Ended 31 December 2025
6th Feb 20264:40 pmRNSHolding(s) in Company
6th Feb 20267:00 amRNSDisposal of 80-85 Tottenham Court Road W1
30th Jan 20264:45 pmRNSTotal Voting Rights
22nd Jan 20269:00 amRNSDirectorate change
15th Jan 202611:00 amRNSHolding(s) in Company
31st Dec 20251:15 pmRNSTotal Voting Rights
31st Dec 20251:15 pmRNSTotal Voting Rights
17th Dec 20257:00 amRNSPlanning success at Blue Star House SW9
9th Dec 20257:00 amRNSBurberry extends commitment to Horseferry House
28th Nov 20254:45 pmRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Business Update
31st Oct 20254:45 pmRNSTotal Voting Rights
21st Oct 20257:00 amRNSStrategic partnership at Old Street Quarter
9th Oct 20257:00 amRNSSuccessful completion of 25 Baker Street
30th Sep 20254:45 pmRNSTotal Voting Rights
30th Sep 202511:00 amRNSHolding(s) in Company
22nd Sep 202512:00 pmRNSBlock listing Interim Review
9th Sep 202511:45 amRNSDirector Declaration
2nd Sep 202511:30 amRNSHolding(s) in Company
29th Aug 20254:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.